Strona korzysta z plików cookies w celu realizacji usług i zgodnie z Polityką Plików Cookies. Możesz określić warunki przechowywania lub dostępu do plików cookies w Twojej przeglądarce.
[ X ]
We are NGS technology leader in Poland
we use the solutions of global giants such as Life Technologies and Illumina INC.
Covid5Test - order our new two-gene RT-LAMP genetic test
Go to the Covid5Test website and order our SARS-CoV-2 RT-LAMP Fast Detection Kit
We have the largest genetic testing offer in the country
We provide commercial solutions in the field of genetics, cooperating with clinics, laboratories and medical offices of different specializations
We are a public company
We have been listed on New Connect Stock Exchange since 2011 .
We are very proud to present you our new website Covid5Test where you can place orders for our revolutionary two-gene RT-LAMP genetic test for SARS-CoV-2.
Click and go to: https://covid5test.com/ [...]
The first News: Specialists from the DNA Research Centre, subsidiary of Polish Inno-Gene Capital Group, have developed an inexpensive and fast COVID-19 RT-LAMP genetic test that gives the result within minutes, with production planned to start next week. [...]
In October, the Poznan DNA Research Centre intends to introduce a new genetic test for detecting the presence of the SARS-COV-2 coronavirus. The test will be performed using a new RT LAMP research method, and its result will be obtained after a few minutes at th [...]
Management Board of INNO-GENE S.A. _Emitent_ informs that on November 3, 2020, it received information from a subsidiary, i.e. DNA Research Center sp.z o.o. on concluding a distribution and promotion agreement for the SARS-CoV-2 RT-LAMP FAST DETECTION KIT produc [...]
The Management Board of INNO-GENE S.A. [Inc] (Issuer) informs that on October 29, 2020 it received information from a subsidiary, i.e. DNA Research Center [Ltd.], about concluding a distribution agreement for the SARS-CoV-2 RT-LAMP FAST DETECTION KIT with LeanTrix [...]
Management Board of INNO-GENE S.A. [Inc] (Issuer) informs that it has received information from a subsidiary, i.e. Centrum Badań DNA sp. Z o.o. [Ltd.] (CBDNA) on signing a contract with MEDICOFARMA S.A. [Inc] . [...]
The Management Board of INNO-GENE S.A. (The Issuer) based in Poznań informs that it has completed the selection of partners and the signing of contracts related to the process of transferring IGD stock to the main market of the WSE. The work schedule provide [...]
Management Board of INNO-GENE S.A. [Inc] (Issuer) informs that on October 6, 2020 it signed an investment agreement with COVIDVAX sp.z o.o. [Ltd.] (KRS 0000845189), headed by prof. Andrzej Mackiewicz. [...]
